EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which helps manufacturers monitor drug safety in an increasingly complex p
A study has found a higher risk of suicidal thoughts in users of Novo Nordisk's GLP-1 agonist-based drugs for diabetes and obesity, even though regulators in the US and EU concluded there w
There’s no escaping the rise of AI adoption and integration. It’s not so much a question of whether you will adopt AI into your business practices, but how.
The clinical research industry has experienced a seismic shift over the past few years, from the pandemic to decentralised trials to technological innovations.
Following her attendance at DIA Europe 2024, Humaira Qureshi from Qinecsa Solutions, discusses the historic challenges of pharmacovigilance and embracing a new future-ready ecosystem.